Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1970 3
1971 1
1972 3
1973 3
1974 3
1976 5
1977 1
1978 6
1979 6
1980 6
1981 4
1982 9
1983 5
1984 5
1985 6
1986 10
1987 13
1988 4
1989 7
1990 7
1991 4
1992 2
1993 7
1994 9
1995 1
1996 3
1997 2
1998 3
2000 6
2001 16
2002 8
2003 11
2004 11
2005 8
2006 7
2007 10
2008 11
2009 9
2010 11
2011 14
2012 20
2013 13
2014 30
2015 47
2016 31
2017 26
2018 23
2019 37
2020 24
2021 35
2022 42
Text availability
Article attribute
Article type
Publication date

Search Results

545 results
Results by year
Filters applied: . Clear all
Page 1
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Rizvi NA, Cho BC, Reinmuth N, Lee KH, Luft A, Ahn MJ, van den Heuvel MM, Cobo M, Vicente D, Smolin A, Moiseyenko V, Antonia SJ, Le Moulec S, Robinet G, Natale R, Schneider J, Shepherd FA, Geater SL, Garon EB, Kim ES, Goldberg SB, Nakagawa K, Raja R, Higgs BW, Boothman AM, Zhao L, Scheuring U, Stockman PK, Chand VK, Peters S; MYSTIC Investigators. Rizvi NA, et al. Among authors: raja r. JAMA Oncol. 2020 May 1;6(5):661-674. doi: 10.1001/jamaoncol.2020.0237. JAMA Oncol. 2020. PMID: 32271377 Free PMC article. Clinical Trial.
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown.
Pore N, Wu S, Standifer N, Jure-Kunkel M, de Los Reyes M, Shrestha Y, Halpin R, Rothstein R, Mulgrew K, Blackmore S, Martin P, Meekin J 3rd, Griffin M, Bisha I, Proia TA, Miragaia RJ, Herbst R, Gupta A, Abdullah SE, Raja R, Frigault MM, Barrett JC, Dennis PA, Ascierto ML, Oberst MD. Pore N, et al. Among authors: raja r. Cancer Discov. 2021 Nov;11(11):2828-2845. doi: 10.1158/2159-8290.CD-20-1543. Epub 2021 Jul 6. Cancer Discov. 2021. PMID: 34230008
An innovative alternative for spherophakia.
Nivean M, Nivean DP, Raja R. Nivean M, et al. Among authors: raja r. GMS Ophthalmol Cases. 2021 Mar 29;11:Doc07. doi: 10.3205/oc000180. eCollection 2021. GMS Ophthalmol Cases. 2021. PMID: 33928004 Free PMC article.
Asparaginase-associated pancreatitis in children.
Raja RA, Schmiegelow K, Frandsen TL. Raja RA, et al. Br J Haematol. 2012 Oct;159(1):18-27. doi: 10.1111/bjh.12016. Epub 2012 Aug 22. Br J Haematol. 2012. PMID: 22909259 Review.
Isolated Sphenoid Sinusitis.
Krishnan RDY, Kumarasekaran P, Raja RV. Krishnan RDY, et al. Among authors: raja rv. Indian J Otolaryngol Head Neck Surg. 2019 Nov;71(Suppl 3):1762-1764. doi: 10.1007/s12070-017-1109-2. Epub 2017 Mar 24. Indian J Otolaryngol Head Neck Surg. 2019. PMID: 31763240 Free PMC article.
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Si H, Kuziora M, Quinn KJ, Helman E, Ye J, Liu F, Scheuring U, Peters S, Rizvi NA, Brohawn PZ, Ranade K, Higgs BW, Banks KC, Chand VK, Raja R. Si H, et al. Among authors: raja r. Clin Cancer Res. 2021 Mar 15;27(6):1631-1640. doi: 10.1158/1078-0432.CCR-20-3771. Epub 2020 Dec 22. Clin Cancer Res. 2021. PMID: 33355200 Clinical Trial.
A cash lottery increases voter turnout.
La Raja RJ, Schaffner BF. La Raja RJ, et al. PLoS One. 2022 Jun 3;17(6):e0268640. doi: 10.1371/journal.pone.0268640. eCollection 2022. PLoS One. 2022. PMID: 35657922 Free PMC article.
545 results